HomeLAURUSLABS • NSE
add
Laurus Labs Ltd
Previous close
₹463.20
Day range
₹459.05 - ₹472.90
Year range
₹349.40 - ₹518.00
Market cap
252.00B INR
Avg Volume
2.45M
P/E ratio
170.26
Dividend yield
0.17%
Primary exchange
NSE
In the news
Financials
Income Statement
Revenue
Net income
| (INR) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 11.95B | 1.11% |
Operating expense | 5.90B | 13.96% |
Net income | 125.10M | -49.66% |
Net profit margin | 1.05 | -50.00% |
Earnings per share | 0.23 | -50.00% |
EBITDA | 1.60B | 1.31% |
Effective tax rate | 33.02% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.42B | 192.30% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 41.16B | — |
Shares outstanding | 543.91M | — |
Price to book | 6.07 | — |
Return on assets | — | — |
Return on capital | 2.53% | — |
Cash Flow
Net change in cash
| (INR) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | 125.10M | -49.66% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Laurus Labs is an Indian multinational pharmaceutical and biotechnology company headquartered in Hyderabad. Its focus areas include active pharmaceutical ingredients, generic formulations, custom synthesis, biotechnology, veterinary APIs and agrochemicals. The company was founded in 2005 by Satyanarayana Chava.
Laurus Labs has its eight manufacturing plants located at Visakhapatnam, Hyderabad and Bangalore. The manufacturing units have received one or more approvals from USFDA, WHO, NIP Hungary, KFDA, MHRA, TGA, and PMDA. The company operates through its subsidiaries in Europe and United States and also offers its services in contract research, clinical research and analytical research through its R&D centers. The R&D centres are based in Hyderabad, Visakhapatnam and United States. Wikipedia
Founded
2005
Website
Employees
6,007
